{"product_id":"next-generation-sequencing-ngs-informatics-market-by-offering-data-analysis-interpretation-reporting-storage-computing-lims-application-diagnostic-drug-discovery-precision-medicine-biomarker-discovery-end-user-global-forecast-to-2030","title":"Next Generation Sequencing (NGS) Informatics Market by Offering (Data Analysis, Interpretation \u0026 Reporting, Storage \u0026 Computing, LIMS) Application (Diagnostic, Drug Discovery, Precision Medicine, Biomarker Discovery) End User - Global Forecast to 2030","description":"\u003cp\u003eNext Generation Sequencing (NGS) Informatics Market by Offering (Data Analysis, Interpretation \u0026amp; Reporting, Storage \u0026amp; Computing, LIMS) Application (Diagnostic, Drug Discovery, Precision Medicine, Biomarker Discovery) End User - Global Forecast to 2030\u003cbr\u003e\nNext Generation Sequencing (NGS) Informatics Market by Offering (Data Analysis, Interpretation \u0026amp; Reporting, Storage \u0026amp; Computing, LIMS) Application (Diagnostic, Drug Discovery, Precision Medicine, Biomarker Discovery) End User — Global Forecast to 2030\u003c\/p\u003e\n\n\u003cp\u003eThe global NGS informatics market is projected to reach $4.3 billion by 2030, at a CAGR of 15.4% from 2023 to 2030.\u003c\/p\u003e\n\n\u003cp\u003eSucceeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. The growth of the NGS informatics market is driven by increasing R\u0026amp;D investments by pharmaceutical and biotechnology companies, the rising prevalence of cancer and genetic disorders, the growing utilization of NGS in disease diagnostics and precision medicine, technological advancements in NGS informatics solutions, and government initiatives supporting large-scale genomic sequencing projects. However, data confidentiality concerns restrain the growth of this market.\u003c\/p\u003e\n\n\u003cp\u003eThe increasing adoption of NGS informatics tools among hospitals and clinical laboratories and the growing use of bioinformatics and genomic data management solutions for large-scale data analysis and interpretation are expected to create growth opportunities for the players operating in the NGS informatics market. However, the lack of skilled professionals required to operate NGS Informatics tools is a major challenge for market growth.\u003c\/p\u003e\n\n\u003cp\u003eBased on offering, in 2023, the software segment is expected to account for the largest share of the market. NGS informatics software enables researchers to efficiently analyze, store, and securely share vast amounts of genomic data. With their cost and time-saving capabilities, robust data security measures, and seamless collaboration features, these software solutions enable effective genomic data management, contributing to the large market share of this segment.\u003c\/p\u003e\n\n\u003cp\u003eBased on application, in 2023, the drug discovery segment is expected to account for the largest share of the market. The growth of this segment is driven by the benefits offered by NGS technology in drug discovery. NGS enables the identification of novel drug targets and the development of therapeutic techniques that target specific genes and proteins, including targeted therapies, gene therapy, and oligonucleotide therapy.\u003c\/p\u003e\n\n\u003cp\u003eBased on end user, in 2023, the pharmaceutical \u0026amp; biotechnology companies segment is expected to account for the largest share of the next generation sequencing (NGS) informatics market. Pharmaceutical \u0026amp; biotechnology companies extensively utilize NGS for high-throughput analysis and genetic-based drug development. The adoption of NGS informatics has enabled efficient management, analysis, and reporting of large volumes of genomic data, thereby supporting remote work and enhancing research capabilities. These factors contribute to the significant market share of this segment.\u003c\/p\u003e\n\n\u003cp\u003eAn in-depth analysis of the geographical scenario of the global NGS informatics market provides detailed qualitative and quantitative insights about the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East \u0026amp; Africa) along with the coverage of major countries in each region. In 2023, North America is expected to account for the largest share of the NGS informatics market, followed by Europe, Asia-Pacific, Latin America, and the Middle East \u0026amp; Africa. The factors supporting the largest share of this market are technological advancements in the region, the increasing prevalence of cancer, and increased healthcare care spending. Additionally, the presence of key players, well-established healthcare infrastructure, and government initiatives for NGS-based diagnostic testing also contribute to the large market share of North America.\u003c\/p\u003e\n\n\u003cp\u003eThe key players operating in the global NGS market are Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Qiagen N.V. (Netherlands), Agilent Technologies, Inc. (U.S.), Sapio Sciences, LLC (U.S.), DNASTAR, Inc. (U.S.), Fabric Genomics, Inc. (U.S.), Partek Incorporated (U.S.), and DNAnexus, Inc. (U.S.).\u003c\/p\u003e\n\n\u003cp\u003eScope of the Report:\u003c\/p\u003e\n\n\u003cp\u003eNext Generation Sequencing (NGS) Informatics Market Assessment—by Offering\u003c\/p\u003e\n\n\u003cp\u003eSoftware\u003c\/p\u003e\n\n\u003cp\u003eBy Type\u003c\/p\u003e\n\n\u003cp\u003eData Analysis Software\u003cbr\u003e\nData Interpretation and Reporting Tools\u003cbr\u003e\nData Storage and Computing Tools\u003cbr\u003e\nLaboratory Information Management Systems (LIMS)\u003c\/p\u003e\n\n\u003cp\u003eBy Deployment mode\u003c\/p\u003e\n\n\u003cp\u003eWeb and Cloud-based\u003cbr\u003e\nOn-premise\u003cbr\u003e\nNGS Informatics Services\u003c\/p\u003e\n\n\u003cp\u003eNext Generation Sequencing (NGS) Informatics Market Assessment—by Application\u003c\/p\u003e\n\n\u003cp\u003eDisease Diagnoses\u003cbr\u003e\nBiomarker Discovery\u003cbr\u003e\nDrug Discovery\u003cbr\u003e\nPrecision Medicine\u003cbr\u003e\nAgriculture and Animal Research\u003c\/p\u003e\n\n\u003cp\u003eNext Generation Sequencing (NGS) Informatics Market Assessment—by End User\u003c\/p\u003e\n\n\u003cp\u003ePharmaceutical and Biotechnology Companies\u003cbr\u003e\nHospitals \u0026amp; Diagnostic Laboratories\u003cbr\u003e\nAcademic \u0026amp; Research Institutes\u003cbr\u003e\nOther End Users\u003c\/p\u003e\n\n\u003cp\u003eNote: Other end users include forensic laboratories \u0026amp; security agencies, food and beverage companies, and agriculture companies.\u003c\/p\u003e\n\n\u003cp\u003eNext Generation Sequencing (NGS) Informatics Market Assessment—by Geography\u003c\/p\u003e\n\n\u003cp\u003eNorth America\u003cbr\u003e\nU.S.\u003cbr\u003e\nCanada\u003cbr\u003e\nEurope\u003cbr\u003e\nGermany\u003cbr\u003e\nFrance\u003cbr\u003e\nItaly\u003cbr\u003e\nU.K.\u003cbr\u003e\nSpain\u003cbr\u003e\nRest of Europe\u003cbr\u003e\nAsia-Pacific\u003cbr\u003e\nChina\u003cbr\u003e\nJapan\u003cbr\u003e\nIndia\u003cbr\u003e\nRest of Asia-Pacific\u003cbr\u003e\nLatin America\u003cbr\u003e\nBrazil\u003cbr\u003e\nMexico\u003cbr\u003e\nRest of Latin America\u003cbr\u003e\nMiddle East \u0026amp; Africa\u003c\/p\u003e\n\n\u003cp\u003eNext Generation Sequencing (NGS) Informatics Market - Report SummaryReport MetricsDetailsYears Considered2021 - 2030Base Year2022Forecast Period2023-2030Page Count203Units ReferencedValue (USD Million)Segments\/Key TopicsMarket by Offering, Application, End UserRegions CoveredNorth America, Europe, Asia-Pacific, Latin America, Middle East \u0026amp; AfricaKey Companies MentionedIllumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Qiagen N.V. (Netherlands), Agilent Technologies, Inc. (U.S.), Sapio Sciences, LLC (U.S.), DNASTAR, Inc. (U.S.), Fabric Genomics, Inc. (U.S.), Partek Incorporated (U.S.), and DNAnexus, Inc. (U.S.).\u003c\/p\u003e\n\n\u003cp\u003eFAQs About the Report\u003c\/p\u003e\n\n\u003cp\u003eWhat is the focus of the next generation sequencing (NGS) informatics market study?\u003c\/p\u003e\n\n\u003cp\u003eThis study offers a detailed assessment of the next generation sequencing (NGS) informatics market and analyzes the market sizes \u0026amp; forecasts based on offering, application, and end user. This report also involves the value analysis of various segments and subsegments of the next generation sequencing (NGS) informatics market at the regional and country levels.\u003c\/p\u003e\n\n\u003cp\u003eWhat is the revenue generated from selling next generation sequencing (NGS) informatics across the globe? At what rate is their demand expected to grow for the next 5-7 years?\u003c\/p\u003e\n\n\u003cp\u003eThe next generation sequencing (NGS) informatics market is projected to reach $4.3 billion by 2030, at a CAGR of 15.4% during the forecast period.\u003c\/p\u003e\n\n\u003cp\u003eBased on offering, which segment is expected to hold the largest share of the market in 2023?\u003c\/p\u003e\n\n\u003cp\u003eThe software segment is expected to account for the largest share of the market in 2023.\u003c\/p\u003e\n\n\u003cp\u003eWhich application segment is expected to hold the largest share of the market in 2023?\u003c\/p\u003e\n\n\u003cp\u003eThe drug discovery segment is expected to hold the largest share of the market in 2023. The large market share of this segment is attributed to the increasing applications of NGS in various clinical and research areas, the rise in global pharmaceutical research and development activities, and the growing need for data management, analysis, and storage in drug discovery.\u003c\/p\u003e\n\n\u003cp\u003eWhat are the key factors supporting the growth of this market? Also, what are the major opportunities for existing market players and new entrants in the global next generation sequencing (NGS) informatics market?\u003c\/p\u003e\n\n\u003cp\u003eThe growth of the NGS informatics market is driven by increasing R\u0026amp;D investments by pharmaceutical and biotechnology companies, the rising prevalence of cancer and genetic disorders, the growing utilization of NGS in disease diagnostics and precision medicine, technological advancements in NGS informatics solutions, and government initiatives supporting large-scale genomic sequencing projects.\u003c\/p\u003e\n\n\u003cp\u003eFurthermore, the increasing adoption of NGS informatics tools among hospitals and clinical laboratories and the growing use of bioinformatics and genomic data management solutions for large-scale data analysis and interpretation are expected to create growth opportunities for the players operating in the NGS informatics market.\u003c\/p\u003e\n\n\u003cp\u003eWho are the major players operating in the global next generation sequencing (NGS) informatics market?\u003c\/p\u003e\n\n\u003cp\u003eThe key players profiled in the next generation sequencing (NGS) informatics market study are Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Qiagen N.V. (Netherlands), Agilent Technologies, Inc. (U.S.), Sapio Sciences, LLC (U.S.), DNASTAR, Inc. (U.S.), Fabric Genomics, Inc. (U.S.), Partek Incorporated (U.S.), and DNAnexus, Inc. (U.S.).\u003c\/p\u003e\n\n\u003cp\u003eWhich regions\/countries are likely to offer significant growth opportunities for the vendors in this market during the analysis period?\u003c\/p\u003e\n\n\u003cp\u003eEmerging economies such as China and India are projected to offer significant growth opportunities to the market players due to rising investments in the healthcare sector and increasing genomic projects in these countries.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"July, 2023 \/ - \/ MCW16231265","offer_id":47647283544370,"sku":null,"price":5010.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/next-generation-sequencing-ngs-informatics-market-by-offering-data-analysis-interpretation-reporting-storage-computing-lims-application-diagnostic-drug-discovery-precision-medicine-biomarker-discovery-end-user-global-forecast-to-2030","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}